Процентът на повлиялите се от илопрост пациенти е 16, 8% (17/ 101), а този в групата на плацебо – 4, 9% (5/ 102) (р=0, 007).
The rate of responders to iloprost was 16.8% (17/ 101) and the rate of responders in the placebo group was 4.9% (5/ 102) (p=0.007).